News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research
Daniel Jones/LinkedIn
Jan 29, 2025, 14:11

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

Daniel Jones,

“I had the privilege of attending ASCO GI to present our team’s research, led by Dr. Kyaw Thein! We were honored to have three meta-analyses accepted for presentation and publication in the Journal of Clinical Oncology.

Here are the links to our research for those interested in exploring them further.”

1. Meta-analysis of randomized controlled trials (RCTs) to evaluate the incidence of hemorrhage and venous thromboembolism (VTE) events in patients with gastrointestinal (GI) cancers treated with fruquintinib.

2. Meta-analysis of phase II/III randomized controlled trials (RCTs) to determine the incidence of hypertension and proteinuria in patients with gastrointestinal (GI) cancers treated with fruquintinib.

3. Meta-analysis of phase II/III randomized controlled trials (RCTs) to evaluate the incidence of hand-foot skin reaction (HFSR) or palmar-plantar erythrodysesthesia (PPE) syndrome in patients with gastrointestinal (GI) cancers treated with fruquintinib.

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

ASCO GI 2025 cancer Daniel Jones Journal of Clinical Oncology Kyaw Thein OncoDaily Oncology
Special Coverage
Drugs
Feb 25, 2025, 16:56
Tarlatamab (Imdelltra): What Patients Need to Know About
Science
Feb 25, 2025, 15:10
Wafaa M Rashed: Genomic Innovation for Economic Development
Drugs
Feb 25, 2025, 14:43
Tarlatamab (Imdelltra): Uses in Cancer, Side Effects, Dosages, Expectations, and More
Blog
Feb 25, 2025, 14:12
5 articles suggested by Wafik El-Deiry
Blog
Feb 25, 2025, 14:04
M. Bilal Abid: Concluded the PANAO 2025 conference
Blog
Feb 25, 2025, 13:56
Jasmin Hundal: What Drives Cancer Risk in Adults vs. Children?
Blog
Feb 25, 2025, 13:46
Enrico Pozzo: I will join Humanitas Research Hospital in Milan as staff member
Career
Feb 25, 2025, 13:39
Patrizia Cavazzoni Rejoins Pfizer as Chief Medical Officer and Executive Vice President
Blog
Feb 25, 2025, 13:38
Sean Burroughs: 2025 Funding Rounds and Growing Therapeutic Trends
Blog
Feb 25, 2025, 13:28
Exploratory analysis of biomarkers and histology in DUO-E pMMR - Spanish Gynaecological Cancer Research Group
Science
Feb 25, 2025, 13:26
Partha Basu: 'Screen, triage and treat' vs 'screen and treat' for WLHIV positive on HPV test
Blog
Feb 25, 2025, 11:39
Applonia Rose: Exciting findings on prognostic scoring in metastatic renal cell carcinoma